UNITED STATES SECURITIES AND EXCHANGE
WASHINGTON, D.C. 20549
CURRENT REPORT PURSUANT TO SECTION 13
OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
January 7, 2013
CHAMPIONS ONCOLOGY, INC.
(Exact name of registrant as specified in
|(State or Other Jurisdiction
||(Commission File Number)
1 University Plaza, Suite 307, Hackensack,
New Jersey 07601
(Address of Principal Executive Offices)
Registrant’s telephone number, including
area code: (201) 808-8400
(Former Name or Former Address if Changed
Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
INFORMATION TO BE INCLUDED IN THE REPORT
On January 7, 2013,
the Company prepared a presentation regarding its business.
A copy of the presentation
is attached hereto as Exhibit 99.1.
|Item 9.01. ||Financial Statements and Exhibits.
exhibit is filed herewith:
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
||CHAMPIONS ONCOLOGY, INC.|
|Date: January 7, 2013
||/s/ Joel Ackerman|
Chief Executive Officer